Comprehensive cost of treating one patient with MDR/pre-XDR-TB in Wellington, New Zealand.
Dept of Respiratory Medicine, Capital and Coast District Health Board, Wellington, New Zealand Dept of Infectious Diseases, Capital and Coast District Health Board, Wellington, New Zealand amanda.mcnaughton@ccdhb.org.nz.
Amanda
A
McNaughton
Medical Research Institute of New Zealand, Wellington, New Zealand.
Timothy
T
Blackmore
Dept of Infectious Diseases, Capital and Coast District Health Board, Wellington, New Zealand.
Harry
H
McNaughton
D000328:Adult; D000583:Amikacin / Q000191:economics / Q000627:therapeutic use; D010131:Aminosalicylic Acid / Q000191:economics / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000191:economics / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000191:economics* / Q000627:therapeutic use; D001999:Bronchoscopy; D002991:Clofazimine / Q000191:economics / Q000627:therapeutic use; D003863:Depression / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000523:psychology; D016527:Drug Costs; D054242:Emigrants and Immigrants; D004977:Ethambutol / Q000191:economics / Q000627:therapeutic use; D054908:Extensively Drug-Resistant Tuberculosis; D024841:Fluoroquinolones / Q000191:economics / Q000627:therapeutic use; D017048:Health Care Costs; D006801:Humans; D007194:India / Q000208:ethnology; D007538:Isoniazid / Q000191:economics / Q000627:therapeutic use; D000069349:Linezolid / Q000191:economics / Q000627:therapeutic use; D008297:Male; D008482:Mediastinum; D008826:Microbial Sensitivity Tests; D000077266:Moxifloxacin; D009520:New Zealand; D011718:Pyrazinamide / Q000191:economics / Q000627:therapeutic use; D013902:Radiography, Thoracic; D012293:Rifampin / Q000191:economics / Q000627:therapeutic use; D012563:Schizophrenia, Paranoid / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000523:psychology; D014388:Tuberculosis, Lymph Node / Q000188:drug therapy / Q000191:economics*; D018088:Tuberculosis, Multidrug-Resistant / Q000150:complications / Q000188:drug therapy / Q000191:economics*; D014396:Tuberculosis, Pleural / Q000188:drug therapy / Q000191:economics*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy / Q000191:economics*
D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents; D024841:Fluoroquinolones; D011718:Pyrazinamide; D010131:Aminosalicylic Acid; D000583:Amikacin; D004977:Ethambutol; D002991:Clofazimine; D000069349:Linezolid; D000077266:Moxifloxacin; D007538:Isoniazid; D012293:Rifampin